Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenomic analysis reveals prevalent contribution of transposable elements to cis-regulatory elements, tissue-specific expression, and alternative promoters in zebrafish. | Genome Res | 2022 | 35649578 | PubTator, text mining | PubMed |
| Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression. | J Cancer Res Clin Oncol | 2022 | 35633416 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma: The Role of MicroRNAs. | Biomolecules | 2022 | 35625573 | PubTator, text mining | PubMed |
| Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression. | Blood Adv | 2022 | 35622975 | PubTator, text mining | PubMed |
| Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. | Cell Rep Med | 2022 | 35617957 | PubTator, text mining | PubMed |
| IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells. | Mol Med Rep | 2022 | 35616130 | PubTator, text mining | PubMed |
| Advances in the Study of CircRNAs in Tumor Drug Resistance. | Front Oncol | 2022 | 35615158 | PubTator, text mining | PubMed |
| Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells. | Front Oncol | 2022 | 35615150 | PubTator, text mining | PubMed |
| Developmental cues license megakaryocyte priming in murine hematopoietic stem cells. | Blood Adv | 2022 | 35584393 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages. | Int J Cancer | 2022 | 35583991 | PubTator, text mining | PubMed |
| Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. | J Hepatol | 2022 | 35577029 | PubTator, text mining | PubMed |
| Multi-omics approach reveals posttranscriptionally regulated genes are essential for human pluripotent stem cells. | iScience | 2022 | 35573189 | PubTator, text mining | PubMed |
| m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. | Front Immunol | 2022 | 35572541 | PubTator, text mining | PubMed |
| Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies. | Oncol Lett | 2022 | 35572491 | PubTator, text mining | PubMed |
| Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma. | Cancers (Basel) | 2022 | 35565317 | PubTator, text mining | PubMed |
| IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2. | Cancers (Basel) | 2022 | 35565249 | PubTator, text mining | PubMed |
| 5-methylcytosine RNA methyltransferases and their potential roles in cancer. | J Transl Med | 2022 | 35562754 | PubTator, text mining | PubMed |
| Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option. | Mol Diagn Ther | 2022 | 35553407 | PubTator, text mining | PubMed |
| Regulation of developmental hierarchy in Drosophila neural stem cell tumors by COMPASS and Polycomb complexes. | Sci Adv | 2022 | 35544555 | PubTator, text mining | PubMed |
| Recent advances of NEAT1-miRNA interactions in cancer. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35538025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=27